Cardiorenal syndrome: Multi-organ dysfunction involving the heart, kidney and vasculature

Area of Science:

• Cardiology
• Nephrology
• Vascular Biology

Background:

• Cardiorenal syndrome (CRS) is a complex multi-organ disease affecting the heart, kidneys, and vasculature.
• It presents significant global health challenges, characterized by high morbidity and mortality.
• Existing therapies are often symptomatic and limited in efficacy.

Purpose of the Study:

• To review the complex pathophysiology of cardiorenal syndrome.
• To discuss the limitations of current therapeutic strategies.
• To explore emerging unconventional contributors and novel therapeutic avenues.

Main Methods:

• Literature review of cardiorenal syndrome pathophysiology and treatment.
• Analysis of neurohormonal, inflammatory, oxidative stress, and metabolic interactions.
• Examination of novel therapeutic strategies and emerging contributors like gut dysbiosis.

Main Results:

• CRS pathophysiology involves intricate interactions between multiple systems.
• Current treatments are insufficient, facing challenges with drug interactions and volume management.
• Preclinical studies suggest novel pathways, including gut microbiome and metabolic factors, show promise.

Conclusions:

• Novel therapeutic strategies are needed to address the complexity of cardiorenal syndrome.
• Emerging research into gut dysbiosis, toxins, and metabolic imbalances offers new paradigms for CRS treatment.
• Further clinical validation of pharmaceuticals targeting alternative pathways is warranted.